Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1999 Aug;54(Suppl 2):S19–S23. doi: 10.1136/thx.54.2008.s19

The pathogenic consequences of a single mutated CFTR gene

U Griesenbach, D M Geddes, E W Alton
PMCID: PMC1765929  PMID: 10451687

Full Text

The Full Text of this article is available as a PDF (106.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonfield T. L., Panuska J. R., Konstan M. W., Hilliard K. A., Hilliard J. B., Ghnaim H., Berger M. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):2111–2118. doi: 10.1164/ajrccm.152.6.8520783. [DOI] [PubMed] [Google Scholar]
  2. Brihaye P., Jorissen M., Clement P. A. Chronic rhinosinusitis in cystic fibrosis (mucoviscidosis). Acta Otorhinolaryngol Belg. 1997;51(4):323–337. [PubMed] [Google Scholar]
  3. Chillón M., Casals T., Mercier B., Bassas L., Lissens W., Silber S., Romey M. C., Ruiz-Romero J., Verlingue C., Claustres M. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med. 1995 Jun 1;332(22):1475–1480. doi: 10.1056/NEJM199506013322204. [DOI] [PubMed] [Google Scholar]
  4. Cohn J. A., Friedman K. J., Noone P. G., Knowles M. R., Silverman L. M., Jowell P. S. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med. 1998 Sep 3;339(10):653–658. doi: 10.1056/NEJM199809033391002. [DOI] [PubMed] [Google Scholar]
  5. Colin A. A., Sawyer S. M., Mickle J. E., Oates R. D., Milunsky A., Amos J. A. Pulmonary function and clinical observations in men with congenital bilateral absence of the vas deferens. Chest. 1996 Aug;110(2):440–445. doi: 10.1378/chest.110.2.440. [DOI] [PubMed] [Google Scholar]
  6. Counahan R., Mearns M. B. Prevalence of atopy and exercise-induced bronchial lability in relatives of patients with cystic fibrosis. Arch Dis Child. 1975 Jun;50(6):477–481. doi: 10.1136/adc.50.6.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dahl M., Tybjaerg-Hansen A., Lange P., Nordestgaard B. G. DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma. Lancet. 1998 Jun 27;351(9120):1911–1913. doi: 10.1016/s0140-6736(97)11419-2. [DOI] [PubMed] [Google Scholar]
  8. Davis P. B., Byard P. J. Heterozygotes for cystic fibrosis: models for study of airway and autonomic reactivity. J Appl Physiol (1985) 1989 May;66(5):2124–2128. doi: 10.1152/jappl.1989.66.5.2124. [DOI] [PubMed] [Google Scholar]
  9. Denning G. M., Anderson M. P., Amara J. F., Marshall J., Smith A. E., Welsh M. J. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature. 1992 Aug 27;358(6389):761–764. doi: 10.1038/358761a0. [DOI] [PubMed] [Google Scholar]
  10. Girodon E., Cazeneuve C., Lebargy F., Chinet T., Costes B., Ghanem N., Martin J., Lemay S., Scheid P., Housset B. CFTR gene mutations in adults with disseminated bronchiectasis. Eur J Hum Genet. 1997 May-Jun;5(3):149–155. [PubMed] [Google Scholar]
  11. Irving R. M., McMahon R., Clark R., Jones N. S. Cystic fibrosis transmembrane conductance regulator gene mutations in severe nasal polyposis. Clin Otolaryngol Allied Sci. 1997 Dec;22(6):519–521. doi: 10.1046/j.1365-2273.1997.00058.x. [DOI] [PubMed] [Google Scholar]
  12. Knudson A. G., Jr, Wayne L., Hallett W. Y. On the selective advantage of cystic fibrosis heterozygotes. Am J Hum Genet. 1967 May;19(3 Pt 2):388–392. [PMC free article] [PubMed] [Google Scholar]
  13. Lissens W., Liebaers I. The genetics of male infertility in relation to cystic fibrosis. Baillieres Clin Obstet Gynaecol. 1997 Dec;11(4):797–817. doi: 10.1016/s0950-3552(97)80014-4. [DOI] [PubMed] [Google Scholar]
  14. Meindl R. S. Hypothesis: a selective advantage for cystic fibrosis heterozygotes. Am J Phys Anthropol. 1987 Sep;74(1):39–45. doi: 10.1002/ajpa.1330740104. [DOI] [PubMed] [Google Scholar]
  15. Mennie M., Gilfillan A., Brock D. J., Liston W. A. Heterozygotes for the delta F508 cystic fibrosis allele are not protected against bronchial asthma. Nat Med. 1995 Oct;1(10):978–979. doi: 10.1038/nm1095-978b. [DOI] [PubMed] [Google Scholar]
  16. Miller P. W., Hamosh A., Macek M., Jr, Greenberger P. A., MacLean J., Walden S. M., Slavin R. G., Cutting G. R. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Am J Hum Genet. 1996 Jul;59(1):45–51. [PMC free article] [PubMed] [Google Scholar]
  17. Morral N., Bertranpetit J., Estivill X., Nunes V., Casals T., Giménez J., Reis A., Varon-Mateeva R., Macek M., Jr, Kalaydjieva L. The origin of the major cystic fibrosis mutation (delta F508) in European populations. Nat Genet. 1994 Jun;7(2):169–175. doi: 10.1038/ng0694-169. [DOI] [PubMed] [Google Scholar]
  18. Pier G. B., Grout M., Zaidi T. S., Olsen J. C., Johnson L. G., Yankaskas J. R., Goldberg J. B. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science. 1996 Jan 5;271(5245):64–67. doi: 10.1126/science.271.5245.64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pier G. B., Grout M., Zaidi T., Meluleni G., Mueschenborn S. S., Banting G., Ratcliff R., Evans M. J., Colledge W. H. Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature. 1998 May 7;393(6680):79–82. doi: 10.1038/30006. [DOI] [PubMed] [Google Scholar]
  20. Pignatti P. F., Bombieri C., Marigo C., Benetazzo M., Luisetti M. Increased incidence of cystic fibrosis gene mutations in adults with disseminated bronchiectasis. Hum Mol Genet. 1995 Apr;4(4):635–639. doi: 10.1093/hmg/4.4.635. [DOI] [PubMed] [Google Scholar]
  21. Pradal U., Castellani C., Delmarco A., Mastella G. Nasal potential difference in congenital bilateral absence of the vas deferens. Am J Respir Crit Care Med. 1998 Sep;158(3):896–901. doi: 10.1164/ajrccm.158.3.9711029. [DOI] [PubMed] [Google Scholar]
  22. Rave-Harel N., Kerem E., Nissim-Rafinia M., Madjar I., Goshen R., Augarten A., Rahat A., Hurwitz A., Darvasi A., Kerem B. The molecular basis of partial penetrance of splicing mutations in cystic fibrosis. Am J Hum Genet. 1997 Jan;60(1):87–94. [PMC free article] [PubMed] [Google Scholar]
  23. Saiman L., Cacalano G., Gruenert D., Prince A. Comparison of adherence of Pseudomonas aeruginosa to respiratory epithelial cells from cystic fibrosis patients and healthy subjects. Infect Immun. 1992 Jul;60(7):2808–2814. doi: 10.1128/iai.60.7.2808-2814.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Schroeder S. A., Gaughan D. M., Swift M. Protection against bronchial asthma by CFTR delta F508 mutation: a heterozygote advantage in cystic fibrosis. Nat Med. 1995 Jul;1(7):703–705. doi: 10.1038/nm0795-703. [DOI] [PubMed] [Google Scholar]
  25. Semczuk M., Kostuch M., Krzyzanowski A., Kwaśniewska A., Wojcierowski J. Identyfikacja mutacji genu CFTR u mezczyzn z azoospermia. Ginekol Pol. 1998 Jun;69(6):506–511. [PubMed] [Google Scholar]
  26. Sharer N., Schwarz M., Malone G., Howarth A., Painter J., Super M., Braganza J. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med. 1998 Sep 3;339(10):645–652. doi: 10.1056/NEJM199809033391001. [DOI] [PubMed] [Google Scholar]
  27. Sibai B. M. Thrombophilias and adverse outcomes of pregnancy--what should a clinician do? N Engl J Med. 1999 Jan 7;340(1):50–52. doi: 10.1056/NEJM199901073400110. [DOI] [PubMed] [Google Scholar]
  28. Smith J. J., Travis S. M., Greenberg E. P., Welsh M. J. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell. 1996 Apr 19;85(2):229–236. doi: 10.1016/s0092-8674(00)81099-5. [DOI] [PubMed] [Google Scholar]
  29. Super M. Factors influencing the frequency of cystic fibrosis in South West Africa. Monogr Paediatr. 1979;10:106–113. [PubMed] [Google Scholar]
  30. Tuerlings J. H., Mol B., Kremer J. A., Looman M., Meuleman E. J., te Meerman G. J., Buys C. H., Merkus H. M., Scheffer H. Mutation frequency of cystic fibrosis transmembrane regulator is not increased in oligozoospermic male candidates for intracytoplasmic sperm injection. Fertil Steril. 1998 May;69(5):899–903. doi: 10.1016/s0015-0282(98)00050-8. [DOI] [PubMed] [Google Scholar]
  31. Warner J. O., Norman A. P., Soothill J. F. Cystic fibrosis heterozygosity in the pathogenesis of allergy. Lancet. 1976 May 8;1(7967):990–991. doi: 10.1016/s0140-6736(76)91862-6. [DOI] [PubMed] [Google Scholar]
  32. Wilschanski M., Zielenski J., Markiewicz D., Tsui L. C., Corey M., Levison H., Durie P. R. Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations. J Pediatr. 1995 Nov;127(5):705–710. doi: 10.1016/s0022-3476(95)70157-5. [DOI] [PubMed] [Google Scholar]
  33. van der Ven K., Messer L., van der Ven H., Jeyendran R. S., Ober C. Cystic fibrosis mutation screening in healthy men with reduced sperm quality. Hum Reprod. 1996 Mar;11(3):513–517. doi: 10.1093/humrep/11.3.513. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES